Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:paracetamol
gptkb:codeine_phosphate |
| gptkbp:availableOn |
gptkb:Australia
|
| gptkbp:broadcastOn |
Schedule 4 (Prescription Only) in Australia
|
| gptkbp:containsCodeineAmount |
15 mg per tablet
|
| gptkbp:containsParacetamolAmount |
500 mg per tablet
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Panadeine Extra
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:notRecommendedFor |
children under 12
people with liver disease people with respiratory depression |
| gptkbp:prescriptionRequired |
yes
|
| gptkbp:previouslyAvailableOverTheCounter |
yes (before 2018 in Australia)
|
| gptkbp:riskFactor |
dependence
liver damage (if overdosed) |
| gptkbp:sideEffect |
nausea
constipation drowsiness |
| gptkbp:usedFor |
pain relief
|
| gptkbp:withdrawnFromOTC |
2018 (Australia)
|
| gptkbp:bfsParent |
gptkb:Panadeine
|
| gptkbp:bfsLayer |
7
|